News
Introduction Marinus Pharmaceuticals (NASDAQ:MRNS), focusing on seizure disorders, got FDA approval in 2022 for Ztalmy (ganaxolone) to treat seizures in CDD patients over two....
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Buyside analyst covering global stocks on Seeking Alpha since 2018. I’ve been investing personally and professionally across major...
News
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
News
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
News
Investment Thesis AT&T (NYSE:T) has ran into terrible news sentiment once again. Despite the company showing quite good Q2 performance, investors still appear to...
News
What happened? It isn’t unheard of for a company to throw shade at competitors on an earnings call, but it is unusual. This is...
News
Women have fought for and won bigger roles in the U.S. military in recent years, but a gap favoring their male counterparts emerges yet...
News
Investors in Invesco QQQ Trust ETF (NASDAQ:QQQ) suffered a steep pullback in August as sellers digested the technology-led ETF (50% weighting), sending it down...
News
Editor’s note: Seeking Alpha is proud to welcome Alex Leeder as a new contributor. It’s easy to become a Seeking Alpha contributor and earn...
News
Rapid Recap Since I penned my analysis of Samsara (NYSE:IOT) titled Inflection Quarter, the stock has been on a tear. Author’s work on Samsara...
News
Investment Thesis GitLab (NASDAQ:GTLB) will report its fiscal Q2 2024 results on Tuesday after hours. I make the case that GitLab is well-positioned with...
News
Wallenius Wilhelmsen (OTCPK:WAWIF)(OTCPK:WILWY) is a RoRo shipping company primarily that has been benefiting from the return to normal in car exports and trade in...
News
Realty Income (NYSE:O) has underperformed the broader market by a wide margin over the last several years. O is widely regarded as one of...
